Data coverage, completeness and provenance for CLEO DIAGNOSTICS LTD in the Stock Market API — Health Care · Medical Devices.
Source date: 2026-10-30T04:27:42. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.2950 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.3000 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.2950 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.2950 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.3050 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/COV/prices · Price parameters and adjustment semantics
No archived filings are currently stored for this listing.
Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Website: https://www.cleodx.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/COV/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 23 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 23 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 24 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 25 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/COV
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/COV/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/COV/metrics/summary
Dated press releases and announcements with source links.
GET /api/v1/companies/COV/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/COV
Free tier — instant API key. Built for AI agents.